Episode Summary
Executive Summary: The episode is partly a subscription pitch for Search Engine’s new premium feed, Incognito Mode, and partly a preview interview about drug adulteration and fentanyl. The core discussion argues that illicit drug users often can’t tell what’s really in their drugs because the market is heavily adulterated, and that even “honest” dealers face a chain of unreliability. The interview offers harm-reduction advice and shows how widespread contamination and distrust shape the drug market.
Main Topics: Launch of Incognito Mode: PJ Vote announces a new paid premium version of the show, pricing, access details, and why the team wants a more experimental, intimate format beyond ad-supported content. The economics of independent media: The host explains that ad revenue alone likely cannot sustain a new, niche show, so audience support is framed as essential to keeping small media projects alive. Why drug adulteration is hard to detect: The interview begins with the question of why fentanyl in cocaine or other drugs often goes unnoticed, with the explanation that U.S. cocaine is already so adulterated that users may not know what pure product feels like. Inside the dealer’s perspective: ‘Nate,’ an anonymized drug dealer, describes testing products, dealing with customer complaints, and trying to maintain ethical standards in a market where many sellers are less careful. Fentanyl testing and false positives: The transcript discusses early fentanyl test strips, their flaws, and the value of newer testing methods, highlighting the role of harm-reduction organizations like Dancesafe. Supply-chain dishonesty and contamination: The dealer recounts being sold highly adulterated ketamine and explains how drugs are often re-cut repeatedly before reaching consumers, making quality control nearly impossible. Harm reduction for listeners: The interview is framed as practical public-health information for people who use drugs or know someone who does, emphasizing testing and caution in an unregulated market.
Key Arguments: Paid subscriptions are becoming a necessary model for small, experimental media projects that cannot rely on ads alone. Many users of illicit drugs cannot detect fentanyl or other adulterants because the baseline quality of street drugs is already poor and inconsistent. An ‘honest’ dealer may test product and try to protect customers, but the supply chain still introduces major contamination risks. Early fentanyl test strips were imperfect and could produce false positives, complicating harm-reduction efforts. Fentanyl is commonly associated with cocaine and heroin, not MDMA, according to both the dealer and Dancesafe testing data. Cocaine sold at street level is often cut repeatedly, so the final product may contain only a small fraction of actual cocaine. When dealers are ripped off, there is little recourse in illegal markets, so bad product is often re-sold rather than refunded or corrected.
Data Points: Annual subscription price: $50/year - Price for Incognito Mode, discounted versus monthly billing Monthly subscription price: $7/month - Alternative pricing for Incognito Mode Support model: Annual plans heavily discounted - Host says annual subscriptions save substantial fee costs First fentanyl testing period: 2019, maybe - Nate estimates when he first encountered fentanyl testing False positives: Almost half the time - Host states the primary fentanyl test method had a high false-positive rate MDMA findings at Dancesafe: 0 confirmed samples with fentanyl - Executive director says Dancesafe has never found fentanyl in lab-confirmed MDMA samples London cocaine purity study: 15% actual cocaine - Nate references a study on street cocaine in London Cutting frequency: 5 or 6 or 7 times - Nate says cocaine can be adulterated repeatedly before reaching gram-bag street sales Ketamine purchase: 1 kilo - Nate describes buying a kilo that turned into unusable material Loss amount: $30,000 - Nate says he gave this amount for the bad ketamine shipment
Pivotal Quotes: "It feels unusual to ask people to pay for something they can have for free." — PJ Vote: Host reflects on the discomfort of launching a paid premium product "The future of media, particularly small, strange projects like ours, is going to look more and more like this." — PJ Vote: Explaining why audience-supported subscriptions are necessary "I think that just users aren't really in a position to complain. And as long as they're getting high at all, I think most people probably are satisfied with their Coke being cut with fentanyl." — Ben Westoff: On why users may not notice fentanyl or other adulterants in cocaine
Implications: For listeners, the episode reframes drug use as a harm-reduction issue shaped by misinformation and adulteration. For media, it argues small shows may need direct audience funding to survive and keep producing experimental work.